|[November 04, 2013]
Research and Markets: Cardiovascular Drugs Worldwide Market Report - with Forecast to 2016
DUBLIN --(Business Wire)--
Research and Markets (http://www.researchandmarkets.com/research/glkqhh/global)
has announced the addition of the "Cardiovascular
Drugs Worldwide Market Report - with Forecast to 2016" report
to their offering.
Analysts forecast the Global Cardiovascular Drugs market to decline at a
CAGR of 10.47 percent over the period 2012-2016. One of the key factors
affecting market growth is the over-dependency of the market on the US.
The Global Cardiovascular Drugs market has also been witnessing an
increase in R&D activities. However, the increase in healthcare
expenditure could be one of the factors that will contribute to the
growth of this market.
Thr report has been prepared based on an in-depth market analysis with
inputs from industry experts. The report covers the Americas, and the
EMEA and APAC regions; it covers the Global Cardiovascular Drugs market
landscape and its growth prospects in the coing years.
Key questions answered in this report:
What will the market size be in 2016 and at what rate will it grow?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by these key
What are the strengths and weaknesses of these key vendors?
Key Topics Covered:
1. Executive Summary
3. Market Coverage
4. Market Landscape
5. Global Anti-hypertensive Drugs Market
6. Best Selling Anti-hypertensive Drugs
7. Global Anti-dyslipidemics Drugs Market
8. Best Selling Anti-dyslipidemic Drugs
9. Global Anti-thrombotics Drugs Market
10. Best Selling Anti-thrombotic Drugs
11. Drug Pipeline Analysis
12. Geographical Segmentation
13. Key Leading Countries
14. Rate of Incidence and Prevalence
15. Vendor Landscape
16. Buying Criteria
17. Market Challenges
18. Market Growth Drivers
19. Drivers and their Impact
20. Impact of Drivers and Challenges
21. Market Trends
22. Key Vendor Analysis
F. Hoffmann-La Roche
Merck & Co
For more information visit http://www.researchandmarkets.com/research/glkqhh/global
[ Back To Technology News's Homepage ]